Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
General Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, 066600 Hebei, China.
J Immunol Res. 2022 Sep 19;2022:7150304. doi: 10.1155/2022/7150304. eCollection 2022.
To investigate the risk factors of axillary lymph node metastasis in patients with invasive breast cancer.
This study retrospectively included 122 cases of invasive breast cancer patients admitted to the First Medical Center of PLA General Hospital from January 2019 to September 2020. According to postoperative pathological results, axillary lymph node metastasis was divided into axillary lymph node metastasis (ALNM) group ( =40) and non-axillary lymph node metastasis (NALNM) group ( =82). General demographic information was collected and compared between the two groups. Collected pathological results included lymphovascular invasion (LVI) and the expression of estrogen receptor (ER), progestogen receptor (PR), human epidermal growth factor receptor 2 (HER-2), and Ki-67 detected by immunohistochemistry. Imaging parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) including apparent diffusion coefficient (ADC), early enhanced rate, and time-intensity curve (TIC) were also included into univariate analysis. The variables with differences between the two groups were compared by univariate analysis, and the related factors of axillary lymph node metastasis were analyzed by logistic regression model.
There was no significant difference in general demographic information between the two groups. No significant differences were found in the positive rates of HER-2, ER, PR, Ki-67, pathological types, and clavicular lymph node metastasis and skin chest wall invasion between the two groups ( > 0.05). The proportion of LVI in ALNM group was significantly higher than that in NALNM group (37.50% vs. 6.10%, < 0.001). The proportion of breast cancer on the left side in the ALNM group was higher than that in the NALNM group, and the difference was statistically significant (70.00% vs. 47.56%, = 0.019). There were no significant differences in the imaging parameters obtained by DCE-MRI between the two groups. Binary logistics regression analysis showed that LVI (OR =12.258, 95% CI =3.681-40.812, < 0.001) and left breast cancer (OR =3.598, 95% CI =1.404-9.219, = 0.008) were risk factors for axillary lymph node metastasis in patients with invasive breast cancer.
The formation of vascular tumor thrombi in breast cancer tissue and left breast cancer are risk factors for axillary lymph node metastasis in invasive breast cancer and might be helpful for preoperative detailed assessment of the patient's condition.
探讨浸润性乳腺癌患者腋窝淋巴结转移的危险因素。
本研究回顾性纳入 2019 年 1 月至 2020 年 9 月期间于解放军总医院第一医学中心就诊的 122 例浸润性乳腺癌患者。根据术后病理结果,将腋窝淋巴结转移分为腋窝淋巴结转移(ALNM)组(n=40)和非腋窝淋巴结转移(NALNM)组(n=82)。收集两组患者的一般人口统计学信息,并进行比较。收集的病理结果包括淋巴血管侵犯(LVI)以及免疫组织化学检测的雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体 2(HER-2)和 Ki-67 的表达。还纳入了动态对比增强磁共振成像(DCE-MRI)的影像学参数,包括表观扩散系数(ADC)、早期增强率和时间-强度曲线(TIC),进行单因素分析。采用单因素分析比较两组间有差异的变量,并采用 logistic 回归模型分析腋窝淋巴结转移的相关因素。
两组患者的一般人口统计学信息无显著差异。两组间 HER-2、ER、PR、Ki-67 阳性率、病理类型、锁骨淋巴结转移和皮肤胸壁侵犯比较,差异均无统计学意义(>0.05)。ALNM 组 LVI 阳性率明显高于 NALNM 组(37.50%比 6.10%,<0.001)。ALNM 组左侧乳腺癌比例高于 NALNM 组,差异有统计学意义(70.00%比 47.56%,=0.019)。两组 DCE-MRI 获得的影像学参数无显著差异。二元逻辑回归分析显示,LVI(OR=12.258,95%CI=3.681-40.812,<0.001)和左侧乳腺癌(OR=3.598,95%CI=1.404-9.219,=0.008)是浸润性乳腺癌患者腋窝淋巴结转移的危险因素。
乳腺癌组织中血管肿瘤栓子的形成和左侧乳腺癌是浸润性乳腺癌腋窝淋巴结转移的危险因素,有助于术前对患者病情进行详细评估。